| miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging M Hackl, S Brunner, K Fortschegger, C Schreiner, L Micutkova, C Mück, ... Aging cell 9 (2), 291-296, 2010 | 405 | 2010 |
| Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review S Madersbacher, N Sampson, Z Culig Gerontology 65 (5), 458-464, 2019 | 307 | 2019 |
| ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma N Sampson, R Koziel, C Zenzmaier, L Bubendorf, E Plas, P Jansen-Dürr, ... Molecular endocrinology 25 (3), 503-515, 2011 | 181 | 2011 |
| The ageing male reproductive tract N Sampson, G Untergasser, E Plas, P Berger The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007 | 157 | 2007 |
| In vitro model systems to study androgen receptor signaling in prostate cancer N Sampson, H Neuwirt, M Puhr, H Klocker, IE Eder Endocr Relat Cancer 20 (2), R49-64, 2013 | 116 | 2013 |
| Re-evaluation of the role of calcium homeostasis endoplasmic reticulum protein (CHERP) in cellular calcium signaling Y Lin-Moshier, PJ Sebastian, LA Higgins, ND Sampson, JE Hewitt, ... Journal of Biological Chemistry 288 (1), 355-367, 2013 | 105 | 2013 |
| A role for TSPO in mitochondrial Ca2+ homeostasis and redox stress signaling J Gatliff, DA East, A Singh, MS Alvarez, M Frison, I Matic, C Ferraina, ... Cell death & disease 8 (6), e2896-e2896, 2017 | 96 | 2017 |
| ROS signaling by NADPH oxidase 5 modulates the proliferation and survival of prostate carcinoma cells M Höll, R Koziel, G Schäfer, H Pircher, A Pauck, M Hermann, H Klocker, ... Molecular carcinogenesis 55 (1), 27-39, 2016 | 83 | 2016 |
| Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer J Kang, F La Manna, F Bonollo, N Sampson, IL Alberts, C Mingels, ... Cancer letters 530, 156-169, 2022 | 75 | 2022 |
| Cancer-associated fibroblasts modify the response of prostate cancer cells to androgen and anti-androgens in three-dimensional spheroid culture T Eder, A Weber, H Neuwirt, G Grünbacher, C Ploner, H Klocker, ... International journal of molecular sciences 17 (9), 1458, 2016 | 71 | 2016 |
| Therapeutic targeting of redox signaling in myofibroblast differentiation and age‐related fibrotic disease N Sampson, P Berger, C Zenzmaier Oxidative medicine and cellular longevity 2012 (1), 458276, 2012 | 69 | 2012 |
| Identification of evolutionarily conserved genetic regulators of cellular aging GT Laschober, D Ruli, E Hofer, C Muck, D Carmona‐Gutierrez, J Ring, ... Aging cell 9 (6), 1084-1097, 2010 | 69 | 2010 |
| Inhibition of Nox4‐dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal‐mediated protumorigenic interactions N Sampson, E Brunner, A Weber, M Puhr, G Schäfer, C Szyndralewiez, ... International journal of cancer 143 (2), 383-395, 2018 | 64 | 2018 |
| The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer I Heidegger, P Massoner, N Sampson, H Klocker Cancer letters 367 (2), 113-121, 2015 | 64 | 2015 |
| Dysregulation of Dkk‐3 expression in benign and malignant prostatic tissue C Zenzmaier, G Untergasser, M Hermann, S Dirnhofer, N Sampson, ... The prostate 68 (5), 540-547, 2008 | 64 | 2008 |
| Attenuated Proliferation and Trans-Differentiation of Prostatic Stromal Cells Indicate Suitability of Phosphodiesterase Type 5 Inhibitors for Prevention and Treatment … C Zenzmaier, N Sampson, D Pernkopf, E Plas, G Untergasser, P Berger Endocrinology 151 (8), 3975-3984, 2010 | 63 | 2010 |
| Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease N Sampson, P Berger, C Zenzmaier BioMed Research International 2014 (1), 131737, 2014 | 58 | 2014 |
| Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation N Sampson, C Zenzmaier, M Heitz, M Hermann, E Plas, G Schäfer, ... Endocrinology 154 (8), 2586-2599, 2013 | 40 | 2013 |
| Phosphodiesterase Type 5 Inhibition Reverts Prostate Fibroblast-to-Myofibroblast Trans-Differentiation C Zenzmaier, J Kern, N Sampson, M Heitz, E Plas, G Untergasser, ... Endocrinology 153 (11), 5546-5555, 2012 | 39 | 2012 |
| SF4 and SFRS14, two related putative splicing factors on human chromosome 19p13. 11 ND Sampson, JE Hewitt Gene 305 (1), 91-100, 2003 | 37 | 2003 |
